ClinicalTrials.gg
Not yet recruitingNCT06221865TRAUMA-TCSPUpdated Jan 24, 2024

Study of the Correlation Between Post-traumatic Stress Disorder and Paradoxical Sleep Behavior Disorder

An observational study in Post Traumatic Stress Disorder and Sleep Disorder, sponsored by University Hospital, Clermont-Ferrand. Not yet recruiting at 1 site in France. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2024-01-24.

Sponsored by University Hospital, Clermont-Ferrand · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2026, 10 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
18 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 144 studies in Stress Disorders, Post-Traumatic with a site in France — 33 open to participants now, 33 under way, 3 of them phase 3. Stress Disorders, Post-Traumatic · France.

Planned enrollment
46th of 63
60 · median 106
Started
2024
with 8 others
Observational
63 of 144
12 open now
Primary completion
2026-01
later than 3 of 32 live
Registered
119th of 144
by date

Among the 144 studies in Stress Disorders, Post-Traumatic with a site in France, this one is the 46th largest by planned enrollment of the 63 observational ones that give a count, is one of 9 that started in 2024, is one of 63 observational ones, reaches primary completion later than 3 of the 32 other live ones, and was the 119th registered.

Stress Disorders, Post-Traumatic

2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.

Browse Stress Disorders, Post-Traumatic studies →

Open to participants now

33 of the 144 studies in Stress Disorders, Post-Traumatic with a site in France are open now. Recruiting first, the newest first:

28 more — sign in →

All 33 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 416 Stress Disorders, Post-Traumatic studies recruiting now, 188 (45%) set no upper age limit and 202 (49%) stop at 75 or younger; 62 take children under 18; 88 take healthy volunteers.

This study: 18 Years to 50 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 144 studies in Stress Disorders, Post-Traumatic with a site in France, or all of them as a file.
02

Study summary

Post-Traumatic Stress Disorder is a psychiatric disorder that occurs after a traumatic event and is estimated to affect 5 to 12% of the general population. Around 70% of patients suffering from this disorder report sleep disorders (sleep apnea, insomnia, recurring nightmares, etc.).

There are specific sleep disorders called Rapid Eye Movement (REM) sleep behavior disorders which correspond to nocturnal restlessness with sometimes violent behavior, often associated with intense dreams during a phase of sleep called REM sleep. These disorders are more frequently found in patients suffering from post-traumatic stress, such as veterans.

However, the physiopathological link between these two disorders is poorly understood and studies on this subject are few in number. Through this study, the investigators wish to demonstrate whether there is a correlation between the severity of Post-Traumatic Stress Disorder and that of Rapid Eye Movement sleep behavior disorder.

The main objective is to study the relationship between the severity of Post Traumatic Stress Disorder (PTSD) and the Rapid Eye Movement (REM) Sleep Behavior Disorder.

This is an observational prospective study based on 4 questionnaires relating to the sleep (PSQI), the severity of the Rapid Eye Movement (REM) Sleep Behavior Disorder (REM RBDSQ, IRBD-SSS) and the severity of the Post-Traumatic Stress Disorder (PCL-5).

Read the detailed description

Type of study: observational prospective study

Study duration : 40 min, one visit at D0 (inclusion isit)

Number of center: 1 (Clermont Ferrand)

Patients: 60 patients suffering from type 1 Post-traumatic Stress Disorder .

Patients will be selected during their consultation, at the CUMP (Medico-Psychological Emergency Cell) of the hospital of Clermont-Ferrand. If patients accept to participate to this study, demographic and clinical data (age, sex, current treatments, medical and surgical history) will be collected. Then, they will complete 4 questionnaires :

  • the Rapid Eye Movement Behavior Disorder Screening Questionnaire (REM RBDSQ)
  • the Rapid Eye Movement Behavior Disorder symptom severity scale score (IRBDSSS)
  • the quality of sleep inventory (PSQI)
  • the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL 5)
03

Conditions studied

  • Post Traumatic Stress Disorder
  • Sleep Disorder

Keywords

  • Post Traumatic Stress Disorder
  • Sleep disorders
  • Rapid eye movement sleep behavior disorder
  • Data Correlation
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

60 patients suffering from type 1 Post-traumatic Stress Disorder (PTSD) will be included in this study. They will be selected during their consultation at the CUMP (Cellule d'Urgence Medico Psychologique) of the hospital of Clermont-Ferrand.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patient aged 18 to 50 years.
  • French speaking.
  • Having a diagnosis of type I Posttraumatic Stress Disorder according to DSM 5.

Exclusion criteria

Exclusion Criteria:

  • Presence of acute mental illnesses in the process of decompensation.
  • Presence of a Central Nervous System disorder (e.g. neurodegenerative diseases, Stroke, Multiple Sclerosis (MS), Narcolepsy, etc.)
  • Patient under guardianship, curatorship, or legal protection.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Severity of the Posttraumatic Stress Disorder score

    This self-questionnaire is completed by the patient during the inclusion visit

    Time frame: Day 0

  2. Severity of the Rapid Eye Movement Behavior Disorder symptom score

    This self-questionnaire is completed by the patient during the inclusion visit

    Time frame: Day 0

Secondary outcomes

  1. The Rapid Eye Movement Behavior Disorder Screening Questionnaire score

    This self-questionnaire is completed by the patient during the inclusion visit

    Time frame: Day 0

  2. The quality of sleep inventory score

    This self-questionnaire is completed by the patient during the inclusion visit

    Time frame: Day 0

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2024; primary completion for Jan 2026, 24 months later.

Of 142 non-industry observational studies under Stress Disorders, Post-Traumatic, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 54. This study's planned 24 months is below that.

Counting every sponsor, half of 149 studies reached it within 34 months; a quarter within 14 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 8, 2024
First posted
Jan 24, 2024
StartEst.
Jan 15, 2024
Primary completionEst.
Jan 15, 2026
CompletionEst.
Jun 1, 2026
Last update
Jan 24, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 24, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06221865
Responsible party
Sponsor
First posted
Jan 24, 2024
Start date
Jan 15, 2024 (estimated)
Primary completion
Jan 15, 2026 (estimated)
Completion
Jun 1, 2026 (estimated)
Last update
Jan 24, 2024

Study contacts

Lise Laclautre
Contact
promo_interne_drci@chu-clermontferrand.fr
334.73.754.963
Livia Fantini
principal investigator · University Hospital, Clermont-Ferrand

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion